Skip to main content
. Author manuscript; available in PMC: 2023 Sep 12.
Published in final edited form as: Life Sci. 2019 Sep 6;235:116851. doi: 10.1016/j.lfs.2019.116851

Figure 7.

Figure 7

shows four studies comparing HIV-infected on cART and cART-naïve patients. The results show significantly increased SMD of cIMT in the group of HIV-infected on cART compared to the cART-naïve group (SMD, 0.75mm; 95% CI, 0.30, 1.19; p=0.001). Heterogeneity for these studies was significant with I2 of 75.2% (p=0.007).